pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Luspatercept
Unknown · small molecule · Transfusion-dependent Non-severe Aplastic Anemia
Luspatercept for Transfusion-dependent Non-severe Aplastic Anemia is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code 2025-KLS-046-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Transfusion-dependent Non-severe Aplastic Anemia
- Status
- active
- Trials
- 1